Lista de obras - F Fenizia - Dominio Público Uruguay

Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients

artículo científico publicado en 2015

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

artículo científico publicado en 2016

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.

artículo científico publicado en 2014

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe

artículo científico publicado en 2018

Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.

artículo científico publicado en 2011

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

artículo científico

External quality assessment for EGFR mutations in Italy: improvements in performances over the time.

artículo científico publicado en 2017

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents

scientific article published on 20 June 2019

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

artículo científico publicado en 2015

Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity

artículo científico publicado en 2016

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA

scientific article published on 09 August 2018

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

scientific article published on 19 July 2016

Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models

artículo científico publicado en 2015

Measuring tumor mutation burden in non-small cell lung cancer: tissue versus liquid biopsy

artículo científico publicado en 2018

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

artículo científico publicado en 2013

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

artículo científico publicado en 2018

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

artículo científico publicado en 2016

The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences

artículo científico publicado en 2015

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

artículo científico publicado en 2019

The role of circulating free DNA in the management of NSCLC

scientific article published on 29 November 2018

Lista de obras de F Fenizia

Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe

Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

External quality assessment for EGFR mutations in Italy: improvements in performances over the time.

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models

Measuring tumor mutation burden in non-small cell lung cancer: tissue versus liquid biopsy

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

The role of circulating free DNA in the management of NSCLC